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1. Introduction
Postpartum uterine infections (PPUIs) are considered 
as one of the main pathologies causing infertility of the 
cow and its culling [1–5]. They are the outcome of the 
combination of a determining factor, pathogens (bacteria), 
and predisposing factors (e.g., retained placenta and 
hypocalcemia) [6,7]. 
Clinically, PPUIs were divided into four forms [8]. 
First, puerperal metritis (PM), with a prevalence of 15%–
20% [9], occurs within 21 days postpartum and can be 
diagnosed based on an abnormal distension of the uterus 
combined with a fetid watery red-brown uterine discharge 
and systemic symptoms. When the systemic symptoms 
are absent, this form of PPUI is called clinical metritis [8]. 
Second, clinical endometritis (CE) is observed more than 
21 days postpartum and can be diagnosed by the presence 
in the vagina of mucopurulent or purulent uterine 
discharge [8,10], with a prevalence between 5% and 26% 
[11]. Third, subclinical endometritis is characterized by 
the absence of clinical symptoms, cytology analyses being 
the only tool for its diagnosis [8]. Fourth, pyometra, a 
rare condition comprising fewer than 5% of cases of PPUI 
[7], is defined by the accumulation of purulent material 
within the uterine lumen with a closed cervix [8]. With a 
high prevalence, the possibility of clinical diagnosis, and 
important economic losses, PM and CE are the PPUIs 
most often confronted and treated by veterinarians in the 
field.
A large variety of therapeutic agents have been 
proposed for the treatment of PM and CE. These treatments 
are based on the intrauterine administration of antibiotics 
(tetracycline, cephapirin) [12,13] and antiseptics (iodine 
solutions) [14] and the parenteral administration of 
antibiotics (penicillin, ampicillin, ceftiofur) [15–18], 
hormones (prostaglandin F2α) [18,19], and supportive 
therapy (nonsteroidal antiinflammatory drugs and sera) 
[20,21]. Due to the diversity of molecules proposed to treat 
PM and CE and the absence of conventional treatment, 
different treatment approaches may exist in the field. 
However, little is known about the state of PM and CE and 
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their management in field conditions. To our knowledge, 
the study of Hehenberger et al. [22] in Switzerland was the 
only survey that was carried out to determine practices of 
veterinarians in the field in dealing with PM and CE. 
In this respect, the practices of veterinarians in Algeria 
toward PM and CE remain unknown. Thus, the objective 
of the current work was to study the practices of Algerian 
veterinarians regarding diagnosis and treatment of PM 
and CE in field conditions, including the influence of 
veterinarian experience, practice of artificial insemination, 
and number of bovine farms managed on those practices.
2. Materials and methods
2.1. Questionnaire 
Collection of information on the practices of veterinarians 
toward PM and CE was carried out using a questionnaire-
based survey. The questionnaire was divided into 
three sections. The first section was designed to collect 
information about veterinarians and their activities, 
including sex, years of experience, main activity, number 
of bovine farms visited, average number of cows per 
farm, and whether the veterinarian practices artificial 
insemination. The second and third sections included 
multiple-choice questions about diagnosis and treatment 
of PM and CE. For each choice, veterinarians were invited 
to indicate the frequency of application on a Likert scale 
(very frequently (more than 80% of cases), frequently 
(40% to 80% of cases), sometimes (10% to 40% of cases), 
rarely (1% to 20% of cases), or never (<1% of cases)). The 
questionnaire was formatted using Google forms and 
submitted to five practicing veterinarians for assessment. 
The questionnaire was then distributed as electronic or 
paper copies to 600 veterinarians. The electronic copies 
were sent by e-mail to veterinarians affiliated with the 
National Center for Artificial Insemination and Genetic 
Improvement (CNIAAG) and the Algerian Veterinary 
Technical Group (GTVA), whereas the paper copies 
were distributed by hand on the occasion of professional 
veterinary meetings.
2.2. Data analysis 
The recovered data were loaded into a statistical package 
(IBM SPSS 20; IBM Corp., Armonk, NY, USA) for 
statistical analysis. 
For descriptive statistics, the frequencies of application 
of diagnosis and treatment of PM and CE were presented 
as ordinal variables on a scale from 1 (never) to 5 (very 
frequently).
Logistic regression was performed to show the 
influence of factors (veterinarians’ characteristics) on 
outcome variables (frequency of using diagnostic and 
therapeutic approaches towards PM and CE). The 
outcome variables were regrouped into 2 categories: (i) 
frequent use (regrouping the modalities of frequently and 
very frequently) and (ii) infrequent use (sometimes, rarely, 
and never). Factors were regrouped as follow: years of 
experience (<10 years, >10 years), main practice (bovine 
vs. other species), number of bovine farms managed (>50 
farms vs. <50 farms), and practice of artificial insemination 
(yes vs. no).
For univariate regression, chi-square analyses were 
performed between each predictor and each outcome 
variable. When P < 0.05, a univariate regression was 
considered and calculation of the odds ratio (OR) and 95% 
confidence interval (CI) was carried out. 
For multivariate regressions, the variables with a P-value 
of <0.2 from the univariate regression were included in a 
series of backward stepwise logistic regressions to obtain a 
minimal model containing only significant variables (P < 
0.05) and the OR and 95% CI were calculated to assess the 
strength of the relationship between two or more factors 
and one outcome variable.
3. Results
One hundred and sixteen questionnaires were completed, 
representing 18.2% of the total surveyed veterinarians.
3.1. General characteristics of the veterinarians
The results revealed that 58.6% (68/116) of veterinarians 
had more than 10 years of experience. The percentages 
of veterinarians practicing bovine medicine and artificial 
insemination were 65.1% (69/106) and 57.4% (66/115), 
respectively. In addition, 53% (61/115) of veterinarians 
monitored 50 or more bovine herds.
3.2. Descriptive results 
3.2.1. Diagnosis of PM
The results on diagnosis showed that 83.5% (81/97) of 
veterinarians measure, frequently or very frequently, body 
temperature. Moreover, 71.8% (74/103) of the veterinarians 
perform transrectal examination by hand, frequently or 
very frequently, to diagnose PM, while only 17.1% (13/76) 
do it by echography. A fetid discharge and fever were 
observed, frequently or very frequently, by 91.0% (101/111) 
and 83.5% (86/103) of surveyed veterinarians, respectively. 
More than 60% of veterinarians observe, frequently or 
very frequently, an appetite loss (74.5%, 70/94), a decrease 
in milk production (69.4%, 68/98), or a distended uterus at 
rectal examination (64.0%, 57/89) (Figure 1).
3.2.2. Treatment of PM
The results of PM treatment are given in Tables 1 and 2. 
They revealed that intrauterine (IU) treatment, mainly 
antibiotics, was applied, frequently or very frequently, 
by 76.4% (55/72) of veterinarians. Tetracyclines are 
used, frequently or very frequently, by 72.2% (70/97) 
of veterinarians. Penicillin-streptomycin association is, 
frequently or very frequently, selected by 53.4% (47/88) of 
surveyed veterinarians. Cephalosporins are used by 32.5% 









































Recombency (n = 84)
Dehydratation (n = 84)
Depression (n = 88)
Distended uterus at rectal exam (n = 89)
Decrease in milk production (n = 98)
Appetite loss (n = 94)
Fever (n = 103)
Fetid vaginal mucus (n = 111)
Very frequent (> 80% of cases)
Frequent  (40-80%  of cases)
Sometimes (10-40% of cases)
Rarely (1-10% of cases)
Never (<1% of cases)
Figure 1. Frequency distribution of the symptoms of PM from the perspective of the responding veterinarians, n = number 
of responses.
Table 2. Frequencies of parenteral antibiotics used by veterinarians in cases of PM. 











Penicillins 42.9% 25.0% 20.2% 3.6% 8.3% 84
Tetracyclines 10.3% 7.4% 4.4% 7.4% 70.6% 80
Cephalosporin 36.4% 14.3% 6.5% 6.5% 36.4% 77
Macrolides 27.5% 20.0% 17.5% 8.8% 26.3% 80
Sulfamides 15.5% 12.7% 23.9% 15.5% 32.4% 71
Aminoglycosides 6.2% 13.8% 13.8% 12.3% 53.8% 65
Quinolones 4.7% 7.8% 12.5% 12.5% 62.5% 64
Phenicols 0% 3.0% 6.1% 9.1% 81.8% 66
Table 1. Frequencies of the intrauterine drugs used in cows with PM. 











Tetracycline 53.6% 18.6% 12.4% 8.2% 7.2% 97
Penicillin-streptomycin 38.6% 14.8% 5.7% 13.6% 27.3% 88
Uterine lavage 20.0% 15.3% 16.5% 14.1% 34.1% 85
Cephalosporin 20.5% 12.0% 19.3% 8.4% 39.8% 83
Potassium permanganate 14.8% 7.4% 17.3% 14.8% 45.7% 81
Penicillin 13.2% 15.8% 14.5% 11.8% 44.7% 76
Iodine solution 7.5% 7.5% 11.3% 17.5% 56.3% 83
Aminoglycoside 2.9% 7.2% 7.2% 8.7% 73.9% 69
Rifaximin 00.0% 4.4% 7.4% 82.4% 5.9% 68
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(27/83) of veterinarians frequently or very frequently. 
In addition, 48.2% (41/85) of responding veterinarians 
perform uterine lavage rarely or never to treat PM. Iodine 
solution, aminoglycosides, and penicillins are rarely or 
never used.
Concerning parenteral administration of drugs, 80% 
of veterinarians perform, frequently or very frequently, 
parenteral antibiotherapy. Penicillins, tetracyclines, and 
cephalosporins are, frequently or very frequently, used 
by more than 50% of veterinarians (Table 1). Macrolides 
are also injected, frequently or very frequently, by 47.5% 
(38/80) of veterinarians. Quinolones and phenicols are 
rarely or never used. Veterinarians included supporting 
therapy frequently or very frequently, particularly vitamins 
(73.1%, 68/93), PGF2α (61.4%, 75/105), and nonsteroidal 
antiinflammatory drugs (68.2%, 60/88).
3.2.3. Diagnosis of CE
Visual examination of vulvar discharge and rectal palpation 
are performed to diagnose CE frequently or very frequently 
by the majority of the veterinarians (91.3%, 94/103 and 
86.7%, 85/98, respectively). Moreover, monitoring body 
temperature and vaginal examination by gloved hand are 
performed frequently or very frequently by 65.1% (54/83) 
and 60.9% (56/92) of veterinarians, respectively.
The results revealed that most veterinarians do not use 
a vaginoscope or a speculum frequently or very frequently 
(29.8% and 17.5%, respectively). Furthermore, 97% of 
veterinarians never use a laboratory.
Pus flakes and mucopurulent vaginal discharge are 
observed frequently or very frequently by 76.7% (79/103) 
and 75.8% (75/99) of veterinarians, respectively. Half of 
veterinarians observe general symptoms and a distended 
uterus in rectal examination (60.2% (56/93), 55.1% 
(49/89), respectively) (Figure 2). 
3.2.4. Treatment of CE
In the case of CE presenting with mucopurulent or 
purulent discharge, an association between general and 
intrauterine treatments was frequently or very frequently 
established by 64.1% (66/103) and 71.3% (72/101) of 
veterinarians, respectively.
PGF2α is used by 78.6% (77/98) of veterinarians 
frequently or very frequently to treat CE and it is used even 
in the absence of a corpus luteum by 56.5% (61/108) of 
veterinarians. 
Intrauterine administration of antibiotics is carried 
out by 87% of veterinarians. Tetracycline and penicillin-
streptomycin association are used frequently or very 
frequently by 57% (49/86) and 58% (51/88) of veterinarians, 
respectively. Cephalosporins are used frequently or very 
frequently by 40.5% (32/79) of veterinarians (Table 3).
The systemic administration of antibiotics is used 
systematically by 53.3% of veterinarians to treat CE. 
Parenteral penicillins were systemically applied frequently 
or very frequently by 64.4% (58/90) of veterinarians, 
whereas macrolides and cephalosporins were frequently 
or very frequently injected by 49.4% (40/83) and 48.2% 
(40/83) of practitioners, respectively (Table 4).
3.3. Univariate analysis 
The results of univariate analysis are presented in Tables 
5 and 6.
3.3.1. Puerperal metritis 
Compared to veterinarians whose main activity was not 
bovine medicine, bovine practitioners (main activity was 
bovine medicine) were 3 times more likely to practice 
palpation of the uterus (83.6% vs. 61.8%, P = 0.022) and 
4.8 times less likely to observe an elevation of temperature 
(75.8% vs. 93.5%, P = 0.037) for diagnosis of PM. They were 






























Distanded uterus in rectal exam  (n = 89
Fever  (n = 88)
General symptoms  (n = 93)
Purulent discharge  (n = 94)
Mucopurulent discharge  (n = 99)
Discharge with purulent akes (n = 103)
Very oen (> 80% of cases)
Frequent  (40-80%  of cases)
Sometimes (10-40% of cases)
Rarely (1-10% of cases)
Never (<1% of cases)
Figure 2. Frequency distribution of the symptoms of CE from the perspective of the responding veterinarians, n = number 
of responses.
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87.5%, P = 0.009), 3.4 times more likely to use parenteral 
cephalosporins (64.4% vs. 34.8%, P = 0.02), and 3.1 times 
less likely to use vitamins to treat PM (65.5% vs. 85.4%, P 
= 0.05).
Veterinarians with more than 10 years of experience 
were 2.7 times less likely to use intrauterine tetracyclines 
(64.9% vs. 83.3%, P = 0.042) and 5.4 times more likely to use 
IU cephalosporins (43.4% vs. 12.5%, P = 0.003) compared 
to veterinarians with less than 10 years of experience.
Inseminators were 4.3 times less likely than those not 
practicing insemination to take body temperatures (75.5% 
vs. 93.0%, P = 0.019) and to observe fever (76.8% vs. 
93.5%, P = 0.021). Inseminators were also 4.7 times more 
likely to use IU cephalosporins (44% vs. 14.3%, P = 0.004), 
5.6 times more likely to not use systemic treatment (27% 
vs. 6.25%, P = 0.023), 4.3 times less likely to use systemic 
penicillin (52.3% vs. 82.9%, P = 0.003), and 2.5 times more 
likely to use systemic cephalosporins (60.1% vs. 38.9%, P 
= 0.053).
In comparison with those monitoring fewer than 50 
bovine farms, veterinarians monitoring more than 50 
farms were 3.1 times less likely to use IU tetracycline (62% 
vs. 83.7%, P = 0.015), and 3.8 times more likely to use IU 
cephalosporin (42.6% vs. 16.2%, P = 0.01). They were also 
2.6 times less likely to use parenteral macrolides (35.6% vs. 
61.1%, P = 0.022).
3.3.2. Clinical endometritis 
When compared to noninseminators, inseminators were 
4.7 times more likely to use echography (37.0% vs. 11.1%, 
P = 0.008) and 2.9 times more likely to use a vaginoscope 
(37.5% vs. 17.1%, P = 0.043) to diagnose CE. They were 
also 2.5 times less likely to observe fever (38.3% vs. 61%, P 
= 0.034) and 2.5 times less likely to observe an alteration 
of the general state of the cow (50.0% vs. 72.5%, P = 0.029). 
Table 3. Frequencies of the intrauterine drugs used in cows with CE. 











Tetracycline 43.0% 14.0% 11.6% 10.5% 20.9% 86
Penicillin-streptomycin 39.8% 18.2% 13.6% 3.4% 25.0% 88
Cephalosporin 34.2% 6.3% 19.0% 5.1% 35.4% 79
Uterine lavage 20.0% 15.0% 12.5% 15.0% 37.5% 80
Potassium permanganate 18.4% 11.8% 13.2% 11.8% 44.7% 76
Penicillin 16.2% 21.6% 14.9% 8.1% 39.2% 74
Other 6.2% 7.7% 9.2% 12.3% 64.6% 65
Diluted betadine 4.1% 13.7% 16.4% 13.7% 52.1% 73
Aminoglycosides 5.8% 8.7% 13.0% 5.8% 66.7% 69
Rifaximin  0% 1.4% 5.8% 15.9% 76.8% 69
Table 4. Frequencies of parenteral antibiotic therapy used in cows with CE. 











Penicillins 38.9% 25.6% 13.3% 7.8% 14.4% 90
Tetracycline 33.3% 27.3% 9.1% 6.1% 24.2% 33
Cephalosporin 32.5% 15.7% 8.4% 12.0% 31.3% 83
Association 31.9% 18.1% 20.8% 9.7% 19.4% 72
Macrolides 25.9% 23.5% 14.8% 9.9% 25.9% 81
Sulfamides 13.2% 11.8% 23.7% 9.2% 42.1% 76
Aminoglycosides 7.2% 14.5% 15.9% 15.9% 46.4% 69
Quinolones 5.9% 8.8% 11.8% 13.2% 60.3% 68
Phenicols 1.5% 3.0% 6.1% 7.6% 81.8% 66
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Table 5. Summary of the results of a univariate logistic regression with statements 
Parameter Bovines as main activity P >10 years of experience P
Palpation of the uterus 3.03 (1.15–8.00) 0.022    
Fever 0.21 (0.046–1.01) 0.037    
Intrauterine tetracycline 0.22 (0.07–0.73) 0.009 0.37 (0.14–0.98) 0.042
Intrauterine cephalosporin     5.37 (1.65–17.47) 0.003
Parenteral cephalosporin 3.40 (1.19–9.74) 0.02    
Parenteral macrolide        
Vitamins 0.32 (0.1–1.04) 0.05
Practice of AI P >50 herds P
Palpation of the uterus        
Taking rectal temperature 0.23 (0.06–0.85) 0.019
Fever 0.23 (0.06–0.86) 0.021    
No parenteral antibiotics 5.55 (1.12–27.65)
Intrauterine tetracycline     0.32 (0.12–0.82) 0.015
Parenteral tetracycline 0.4 (0.16–0.97) 0.042
Intrauterine cephalosporin 4.71 (1.57–14.15) 0.004 3.84 (1.34–10.91) 0.01
Parenteral cephalosporin  2.46 (0.98–6.15) 0.053     
Parenteral penicillins 0.23 (0.082–0.62) 0.003
Parenteral macrolides     0.35 (0.14–0.87) 0.022
Table 6. Summary of the results of the univariate logistic regression model for statements regarding the diagnosis and 
treatment of CE. 
Parameter Bovines as main activity P >10 years of experience P
Rectal temperature 0.29 (0.1–0.84) 0.019    
Fever 0.23 (0.09–0.61) 0.003 0.44 (0.18–1.03)   0.056
Distended uterus     2.52 (1.06–5.97) 0.034
Intrauterine tetracycline 0.30 (0.11–0.80) 0.014    
Intrauterine cephalosporin 4.17 (1.41–12.34) 0.008 3.16 (1.21–8.28) 0.017
Parenteral antibiotics systematically 0.40 (0.17–0.96) 0.037    
PGF2α without corpus luteum     2.33 (1.06–5.10) 0.033
Practice of AI P >50 herds P
Echography 4.69 (1.41–15.56) 0.008    
Vaginoscopy 2.90 (1.01–8.33) 0.043    
Fever 0.4 (0.17–0.94) 0.034 0.28 (0.12–0.67) 0.004
Alteration of the general state 0.38 (0.16–0.92) 0.029 0.30 (0.13–0.74) 0.007
Intrauterine tetracycline     0.34 (0.14–0.83) 0.017
Intrauterine cephalosporin 8.70 (2.84–26.69) <0.001 2.60 (1.01–6.70) 0.046
Parenteral antibiotics systematically 0.31 (0.14–0.70) 0.004 0.35 (0.16–0.79) 0.01
Parenteral macrolides     0.38 (0.15–0.94) 0.034
Parenteral vitamins     0.2 (0.08–0.52) 0.001
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Furthermore, inseminators were 3.2 times less likely to use 
parenteral antibiotics systematically (40.7% vs. 68.9%, P = 
0.004) and 8.7 times more likely to use IU cephalosporin 
for CE treatment (60.0% vs. 14.7%, P < 0.001).
Bovine practitioners were 3.4 times less likely to 
measure body temperature (51.1% vs. 78.6%, P = 0.019) 
and 4.3 times less likely to observe fever (32.7% vs. 67.9%, 
P = 0.003). They were also 3.3 times less likely to use IU 
tetracycline (41.3% vs. 70.0%, P = 0.014), 2.5 times less 
likely to use parenteral antibiotics systematically (41.3% 
vs. 63.6%, P = 0.037), and 4 times more likely to use IU 
cephalosporins (55.6% vs. 23.1%, P = 0.008) for CE 
treatment.
Veterinarians with more than 10 years of experience 
were 2 times less likely to observe fever (40% vs. 60.5%, P 
= 0.056) and 3 times more likely to note a distended uterus 
(64.7% vs. 41.7%, P = 0.034). They were 3 times more likely 
to use IU cephalosporins (52.3% vs. 25.7%, P = 0.017) 
and 2 times more likely to use PGF2α in the absence of a 
corpus luteum (65.1% vs. 44.4%, P = 0.033). 
Veterinarians monitoring more than 50 bovine farms 
were 3.6 times less likely to observe fever (33.3% vs. 64.3%, 
P = 0.004) and 3.3 times less likely to observe alteration of 
the general state of the cow (46.9% vs. 74.4%, P = 0.007). 
They were also 2.9 times less likely to use tetracyclines 
(44.2% vs. 69.8%, P = 0.017) and 2.6 times more likely to 
use IU cephalosporins (50.0% vs. 27.8%, P = 0.046). In 
addition, they were 2.9 times less likely to use parenteral 
antibiotics systematically (48.9% vs. 66.0%, P = 0.01), 2.6 
times less likely to use systemic macrolides (39.1% vs. 
62.9%, P = 0.034), and 5 times less likely to use vitamins 
(43.5% vs. 79.5%, P = 0.001).
3.4. Multivariate analysis 
Inseminators were 4 times more likely to use IU 
cephalosporins to treat PM and 5 times more likely to 
treat CE. Likewise, veterinarians with more than 10 
years of experience were 4 times more likely to use IU 
cephalosporins to treat PM. Moreover, bovine practitioners 
were 3 times less likely to observe hyperthermia in cases of 
CE (Table 7).
4. Discussion
The present survey was undertaken to investigate practices 
of Algerian veterinarians in the diagnosis and treatment 
of PM and CE. We hypothesize that factors related to the 
experience of the veterinarians, their practice of AI, main 
activity, and number of farms monitored may influence 
their practices towards the uterine infections. 
It was reported that clinical diagnosis of PM is based on 
the presence of general and local signs including purulent 
vaginal discharge, fever, appetite loss, decrease in milk 
production, and distended uterus [8,10,23]. In our survey, 
these signs were adopted by most veterinarians for PM 
diagnosis. Moreover, the surveyed veterinarians indicated 
that signs of intoxication are rarely present, which may 
be related to early diagnosis before intensification of the 
animal’s state and the appearance of signs of intoxication. 
A similar survey conducted with Swiss veterinarians 
reported the same results for PM diagnosis [22].
The use of systemic antibiotics is the conventional 
treatment of PM [17,24]. In our study, the majority of 
Algerians veterinarians used systemic antibiotics for PM. 
A similar result was observed for Swiss practitioners [22]. 
In the current survey, practitioners used penicillins most 
often, followed by tetracyclines, cephalosporins, and 
aminoglycosides. Likewise, in a study in Sweden, PM was 
treated principally with penicillins and secondarily with 
tetracyclines. In the same study, cephalosporins were 
not used by veterinarians [25]. In this study, the choice 
of the treatment was based on the recommendations of 
the Swedish policy recommending penicillin as the first 
choice antibiotic for PM [25]. Tetracyclines, however, were 
the principal antibiotics reported by Swiss veterinarians 
for PM treatment [13]. Different studies were conducted 
to reveal the optimum antibiotics for PM. In this respect, 
the efficiency of tetracycline and penicillins requires 
their use at high concentrations, which enhances their 
withdrawal periods in meat and milk [26]. Cephalosporin 
is efficient at recommended doses. Furthermore, at the 
recommended dose, high concentrations of cephalosporin 
were observed in the serum, endometrium, caruncles, 
cotyledons, and lochia with no withdrawal periods [26–
Table 7. Summary of the results of a series of multivariable logistic regression models for statements regarding the diagnosis and 
treatment of PM and CE. 
Parameter for PM >10 years of experience P Practice of AI P
Intrauterine cephalosporin 3.8(1.13–13.36) 0.031 3.5 (1.02–12.23) 0.046
Parameter for CE Bovines as main activity P >10 years of experience P Practice of AI P
Hyperthermia 0.29 (0.11–0.83) 0.02 0.26 (0.18–1.34) 0.16
Intrauterine cephalosporin 2.8 (0.91–8.76) 0.072 5.1 (1.58–16.84) 0.007
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28]. In order to show the antibiotics of choice for PM, 
Smith et al. compared penicillin G and cephalosporin. No 
difference in terms of cure was observed between the two 
tested antibiotics [13]. Thus, cephalosporin seems more 
appropriate for systemic treatment of PM. The lack of use 
of cephalosporin in our study may be attributed to its price 
and its relatively recent introduction to the field compared 
to penicillins and tetracyclines. In our survey, bovine 
practitioners and inseminators more frequently used 
cephalosporins, which may be due to their more frequent 
dealings with bovine pathologies including PM, allowing 
the adoption of the appropriate treatment.  
In the present survey, almost 80% of surveyed 
veterinarians performed intrauterine treatment for 
PM with tetracycline and to a lesser extent with 
penicillin-streptomycin and cephalosporin, respectively. 
Inseminators and veterinarians monitoring more than 50 
bovine farms used more IU cephalosporin. In a similar 
survey in Switzerland [22], the results revealed that more 
than 90% of veterinarians performed intrauterine therapy 
using tetracycline and cephalosporin, but not penicillin-
streptomycin. Many studies showed beneficial effects 
of IU use of oxytetracycline at high doses [9], but other 
studies reported the noneffectiveness [13]. In addition it is 
irritating to the endometrium and alters local immunity. 
However, our survey, like that in Switzerland, revealed 
that tetracyclines are still used by veterinarians for PM 
treatment.    
In association with antibiotics, several molecules are 
used to reinforce the treatment for uterine infections. 
Among these molecules, PGF2α and nonsteroid 
antiinflammatory drugs are the most often implicated in 
PM treatment. Regarding PGF2α, it is used for its luteolytic 
effect, uterotonic nature, and leukocyte stimulation. 
However, many studies reported no effect of PGF2α when 
used to treat uterine infection. In our survey and that in 
Switzerland, PGF2α was used systematically despite the 
contradictory results concerning its effect. In cases of PM, 
one study evaluated the use of PGF2α as a complementary 
treatment to cephalosporin. It was concluded that 2 doses 
of PGF2α were beneficial for primiparous cows having PM 
but not for multiparous cows [29]. 
Concerning nonsteroid antiinflammatory drugs, the 
Algerian veterinarians, like those of Switzerland [22], 
frequently use them in association with antibiotics. The 
use of nonsteroid antiinflammatory drugs in cases of PM 
may be explained by the presence of fever. However, there 
is a contradiction regarding the benefits of nonsteroid 
antiinflammatory drugs in PM. Amiridis et al. showed 
a more rapid uterine involution and onset of ovarian 
activity in animals having PM treated by nonsteroid 
antiinflammatory drugs (flunixin meglumine) in addition 
to systematic antimicrobials [30]. On the contrary, other 
studies found no superior effect when these drugs were used 
in combination with antibiotics [31,32]. Further studies 
are required to provide evidence-based medicine with the 
proof about the use of nonsteroid antiinflammatory drugs 
to treat PM.  
Clinical endometritis is a uterine infection occurring 
after 21 days postpartum, characterized by the presence 
of purulent material in the vagina [8]. In the present 
study, the surveyed veterinarians observed CE between 
22 and 30 days postpartum. Furthermore, they frequently 
observed local symptoms by visual exam of the vulvar 
discharge and rectal palpation. Likewise, the survey in 
Switzerland revealed that CE was diagnosed between 21 
and 35 days postpartum by local symptoms. Moreover, 
in this study, rectal palpation and vaginal examination 
were the diagnostic tools used [22]. Previous clinical 
studies reported that efficient tools for CE diagnosis are 
detection of purulent material in the vagina by gloved 
hand or vaginoscope and rectal palpation of the uterus 
combined with external inspection of vulvar discharge 
[11]. In the current survey, Algerian veterinarians used 
rectal palpation of the uterus and external inspection 
of vulvar discharge to diagnosis CE. Concerning Swiss 
veterinarians, diagnosis is based on rectal palpation and 
detection of purulent material in the vagina by gloved 
hand. CE diagnosis tools adopted by Algerian and Swiss 
veterinarians could be justified by their efficiency and 
practicability, not requiring an instrument (vaginoscope). 
In our survey as well as in the survey performed 
in Switzerland [22], PGF2α is used by the majority of 
veterinarians for treating CE. Previous studies showed 
that PGF2α is efficient in the treatment of CE when a 
corpus luteum exists. Thus, the purpose of inclusion 
of PGF2α in CE treatment is to provoke luteolysis, the 
apparition of estrus, and subsequent uterine contractility. 
These processes lead to clearance of the uterine cavity. 
Moreover, PGF2α improves the local immunity of the 
uterus and the recovery of the physiologic uterine state 
[33,34]. In addition, PGF2α was reported to be preferred 
to antibiotics due to its null withdrawal period and its 
lack of implication in the emergence of resistant bacteria 
[35]. In cases of CE with absence of a corpus luteum, 
several clinical trials showed conflicting results about the 
efficiency of PGF2α [12,36,37]. In our survey, an important 
part of the veterinarians used PGF2α in the absence of a 
corpus luteum. Even in the absence of a corpus luteum, 
PGF2α increases leukotriene B4 secretion by the uterus, 
which supports chemotaxis, cell-mediated cytotoxicity, 
phagocytosis, and lymphocyte function [34]. This may 
justify its use by the surveyed Algerian veterinarians. 
Intrauterine administration of antibiotics is considered 
as the best approach for CE. This is because infection is 
limited to the endometrium. In our study, tetracycline 
9RAHAB et al. / Turk J Vet Anim Sci
is used by most surveyed veterinarians. However, Swiss 
veterinarians mainly used IU cephalosporin for CE [22]. 
The selection of tetracycline by Algerian veterinarians 
may be attributed to its high endometrial concentration 
and its poor absorption after intrauterine administration 
[38]. However, bacteriological studies showed that a large 
part of bacteria causing uterine infection are resistant 
to tetracycline [39–44]. Cephapirin is reported as the 
most appropriate antibiotic for treatment of CE and the 
effectiveness of cephalosporin against uterine pathogens 
was proven in vitro [39–44]. In addition, it has no 
withdrawal period in milk and meat. In our study, the 
multivariate analysis indicated that inseminators, whatever 
their experience, used IU cephalosporin more frequently 
to treat CE. This may indicate that inseminators are more 
concerned about uterine health, which is a determinant 
factor for the success of AI.
Systemic antibiotics are also used by Algerian 
veterinarians (more than half) to treat CE. In the Swiss 
survey, most of the veterinarians did not use systemic 
antibiotics. It was reported that administration of 
antibiotics within the uterus is efficient to treat CE without 
a need for further systemic antibiotics. Furthermore, the 
use of systemic antibiotics is costly and requires long 
withdrawal period in milk. Thus, the parenteral use of 
antibiotics in cases of CE by Algerian veterinarians is not 
justified.
Finally, we conclude that the diagnoses of PM and CE 
by surveyed veterinarians are close to the reported criteria. 
However, a contradiction in the treatment for CE and PM 
is observed, particularly in the use of IU antibiotics in 
PM and PGF2 in the absence of a corpus luteum in CE. 
Moreover, some antibiotics used are not reported in the 
literature, like macrolides and penicillin-streptomycin 
association. Inseminators seem more interested in looking 
for recent advances about treatment of uterine infection 
and updating their treatment approaches accordingly.
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